Revolutionizing platelet-based therapies

Cellphire Therapeutics is developing next generation platelet-based therapeutics that are long-term shelf stable and could more rapidly treat bleeding.
‍
Until now, donated platelets had a shelf life of 5 to 7 days. But our patented technology allows us to freeze-dry platelets—stabilizing them—so they can last for years. Our investigational product, Thrombosomes®, once approved, could be given to anyone, anywhere, any time.